| Small & Micro Cap project

Caligan argues that Amag Pharmaceuticals has a collection of valuable assets

by | Nov 4, 2019

Caligan Partners, LP was founded by David Johnson and Sam Merksamer in 2017.

Even though Caligan Partners has filed a 13D in two stocks, Merksamer is no stranger to activism. He served as a managing director of Icahn Capital for eight years before launching Caligan Partners.

In October 2019, Amag Pharmaceuticals entered into a settlement agreement with Caligan after the investment firm launched a consent solicitation process to remove four board candidates. Caligan Partners argued that the individual components of the company’s portfolio are worth more than $30 per share, and the company enjoys several competitive advantages.


Snowball Research,

65, Sakhi Garden, 2nd Cross Street,

Okkiam Thoraipakkam, OMR, Chennai, India

Mobile: 979-0937-345



Snowball Research is an independent research firm. We do not provide personal investment advice. Kindly read our Terms of Use

Copyright by Snowball Research / March Intelligence Research LLP.  All rights reserved.